CTCBIO Inc. (KOSDAQ:060590)

Market Cap	94.92B -43.3%
Revenue (ttm)	132.76B -4.5%
Net Income	2.64B
EPS	110.61
Shares Out	23.91M
PE Ratio	35.78
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	74,206
Average Volume	109,525
Open	3,905.00
Previous Close	3,970.00
Day's Range	3,905.00 - 4,030.00
52-Week Range	3,635.00 - 7,680.00
Beta	-0.11
RSI	42.49
Earnings Date	Mar 20, 2026

About CTCBIO

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC cov...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1993
• Employees: 248
• Stock Exchange: KOSDAQ
• Ticker Symbol: 060590

Financial Performance

In 2024, CTCBIO's revenue was 144.41 billion, an increase of 4.74% compared to the previous year's 137.88 billion. Losses were -5.22 billion, -66.51% less than in 2023.